BridgeBio Oncology Therapeutics, Inc (BBOT)

Last Closing Price: 1.80 (2026-11-18)

Receiveable Turnover (Quarterly)

Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable

BridgeBio Oncology Therapeutics, Inc (BBOT) Receiveable Turnover data is not available.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-34.18M
--
--
$37.49M
$-37.49M
$3.31M
$-34.18M
$-34.18M
$-34.18M
$-34.18M
$-34.18M
$-34.18M
$-37.49M
$-37.30M
80.19M
80.19M
$-0.43
$-0.43
Balance Sheet Financials
$208.33M
$0.81M
$137.90M
$346.22M
$51.03M
--
$1.81M
$52.84M
$293.39M
$293.39M
$293.39M
80.23M
Cash Flow Statement Financials
$-108.64M
$-189.34M
$0.77M
$373.82M
$76.61M
$-297.21M
$15.84M
--
--
Fundamental Metrics & Ratios
4.08
--
--
--
--
--
--
--
--
--
--
$-108.73M
--
--
--
--
--
Receiveable Turnover
--
--
-11.65%
-11.65%
-9.87%
-11.65%
$3.66
$-1.36
$-1.35